Merz Pharms Drug Patent Portfolio

Merz Pharms owns 1 orange book drug protected by 2 US patents Given below is the list of Merz Pharms's drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US7638552 Method for increasing the bioavailability of glycopyrrolate 20 Aug, 2023 Expired
US7816396 Method for increasing the bioavailability of glycopyrrolate 20 Aug, 2023 Expired


Given below is the list of recent legal activities going on the following drug patents of Merz Pharms.

Activity Date Patent Number
Patent litigations
Payment of Maintenance Fee, 12th Year, Large Entity 12 Apr, 2022 US7816396
Payment of Maintenance Fee, 12th Year, Large Entity 16 Jun, 2021 US7638552 (Litigated)
Payment of Maintenance Fee, 8th Year, Large Entity 11 Apr, 2018 US7816396
Email Notification 07 Dec, 2012 US7816396
Change in Power of Attorney (May Include Associate POA) 07 Dec, 2012 US7638552 (Litigated)
Email Notification 07 Dec, 2012 US7638552 (Litigated)
Change in Power of Attorney (May Include Associate POA) 07 Dec, 2012 US7816396
Correspondence Address Change 21 Nov, 2012 US7638552 (Litigated)
Correspondence Address Change 21 Nov, 2012 US7816396
Email Notification 30 Aug, 2011 US7638552 (Litigated)
Change in Power of Attorney (May Include Associate POA) 30 Aug, 2011 US7638552 (Litigated)
Email Notification 29 Aug, 2011 US7816396
Change in Power of Attorney (May Include Associate POA) 29 Aug, 2011 US7816396
Correspondence Address Change 26 Aug, 2011 US7816396
Correspondence Address Change 26 Aug, 2011 US7638552 (Litigated)


Merz Pharms's Family Patents


Family Patents



Merz Pharms Drug List

Given below is the complete list of Merz Pharms's drugs and the patents protecting them.


1. Cuvposa

Cuvposa is protected by 2 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US7638552 Method for increasing the bioavailability of glycopyrrolate 20 Aug, 2023
(1 year, 1 month ago)
Expired
US7816396 Method for increasing the bioavailability of glycopyrrolate 20 Aug, 2023
(1 year, 1 month ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Cuvposa's drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List